Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Current Assets (2016 - 2025)

Apyx Medical (APYX) has disclosed Current Assets for 16 consecutive years, with $58.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets rose 3.6% year-over-year to $58.5 million, compared with a TTM value of $58.5 million through Dec 2025, up 3.6%, and an annual FY2025 reading of $58.5 million, up 3.6% over the prior year.
  • Current Assets was $58.5 million for Q4 2025 at Apyx Medical, up from $48.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $70.4 million in Q4 2023 and bottomed at $43.0 million in Q4 2022.
  • Average Current Assets over 5 years is $55.1 million, with a median of $53.8 million recorded in 2022.
  • The sharpest move saw Current Assets fell 29.25% in 2022, then soared 63.74% in 2023.
  • Year by year, Current Assets stood at $60.7 million in 2021, then fell by 29.25% to $43.0 million in 2022, then skyrocketed by 63.74% to $70.4 million in 2023, then dropped by 19.79% to $56.4 million in 2024, then grew by 3.6% to $58.5 million in 2025.
  • Business Quant data shows Current Assets for APYX at $58.5 million in Q4 2025, $48.8 million in Q3 2025, and $49.9 million in Q2 2025.